欢迎来到淘文阁 - 分享文档赚钱的网站! | 帮助中心 好文档才是您的得力助手!
淘文阁 - 分享文档赚钱的网站
全部分类
  • 研究报告>
  • 管理文献>
  • 标准材料>
  • 技术资料>
  • 教育专区>
  • 应用文书>
  • 生活休闲>
  • 考试试题>
  • pptx模板>
  • 工商注册>
  • 期刊短文>
  • 图片设计>
  • ImageVerifierCode 换一换

    溶栓和急诊PCI在急性心梗治疗中的作用课件.ppt

    • 资源ID:74237366       资源大小:1.38MB        全文页数:49页
    • 资源格式: PPT        下载积分:20金币
    快捷下载 游客一键下载
    会员登录下载
    微信登录下载
    三方登录下载: 微信开放平台登录   QQ登录  
    二维码
    微信扫一扫登录
    下载资源需要20金币
    邮箱/手机:
    温馨提示:
    快捷下载时,用户名和密码都是您填写的邮箱或者手机号,方便查询和重复下载(系统自动生成)。
    如填写123,账号就是123,密码也是123。
    支付方式: 支付宝    微信支付   
    验证码:   换一换

     
    账号:
    密码:
    验证码:   换一换
      忘记密码?
        
    友情提示
    2、PDF文件下载后,可能会被浏览器默认打开,此种情况可以点击浏览器菜单,保存网页到桌面,就可以正常下载了。
    3、本站不支持迅雷下载,请使用电脑自带的IE浏览器,或者360浏览器、谷歌浏览器下载即可。
    4、本站资源下载后的文档和图纸-无水印,预览文档经过压缩,下载后原文更清晰。
    5、试题试卷类文档,如果标题没有明确说明有答案则都视为没有答案,请知晓。

    溶栓和急诊PCI在急性心梗治疗中的作用课件.ppt

    S.Chiu Wong MD,FACCAssociate Professor of MedicineWeill Medical College of Cornell UniversityDirector,Cardiac Catheterization LaboratoriesThe New York Presbyterian Hospital-Cornell CampusThe ACC Symposium at the Great Wall Meeting,Beijing ChinaOctober 17,2004Thrombolysis or Primary PCI in the Treatment of Acute MIPatho-anatomy of AMIFibrinolysis for AMIFibrinolysis Vs.Primary PCIAdjunct Pharmacology and StrategiesCurrent Recommendations in Treatment of AMIThrombolysis or PCI in AMI SummaryPatho-anatomy of AMIFibrinolysis for AMIFibrinolysis Vs.Primary PCIAdjunct Pharmacology and StrategiesCurrent Recommendations in Treatment of AMIThrombolysis or PCI in AMI Circulation,Volume XLV,January 1972.Page 215-230Coronary Arteries in Fatal AcuteMyocardial InfarctionBy WILLIAM C.ROBERTS,M.D.SUMMARY The coronary arteries are diffusely involved by atherosclerotic plaques in fatal acute myocardial infarction(AMI).The degree of luminal narrowing may vary but plaques are present in practically every millimeter of extramural coronary artery.Usually the lumens of at least two of the three major coronary arteries are narrowed 75%by old plaques in patients who die suddenly(75 yrs and treated 12 hrs from sx onset were.The earlier treatment initiation,the greater the benefit and thus re-affirm the concept of “time is muscle.”Not every patient is eligible for thrombolytic treatmentCerebral/vascular bleedPercent AMI pts with TIMI 3 flow following thrombolysis is less than ideal Thrombolysis or PCI in AMI Limitations of Thrombolysis in AMI PatientsThrombolysis or PCI in AMI Contraindications for fibrinolytics in AMIContraindicationsPrevious hemorrhagic stroke at any time;other strokes or cerebrovascular events within 1 yrKnown intracranial neoplasmActive internal bleeding(does not include menses)Suspected aortic dissectionAdapted from Ryan TJ,et al.ACC/AHA guidelines for the management of patients with AMI.J Am Coll Cardiol 1996;28:13281428Relative contraindicationsSevere uncontrolled hypertension on presentation(blood pressure 180/110 mm Hg)or chronic history of severe hypertensionHistory of prior cerebrovascular accident or known intracerebral pathology not covered in contraindicationsCurrent use of anticoagulants in therapeutic doses(international normalized ratio 23);known bleeding diathesisRecent trauma(within 24 wk),including head trauma or traumatic or prolonged(10 min)cardiopulmonary resuscitation or major surgery Noncompressible vascular puncturesRecent(within 24 wk)internal bleedingFor streptokinase/anistreplase:prior exposure(especially within 5 d2 yr)or prior allergic reactionPregnancy and Active peptic ulcerAdapted from Ryan TJ,et al.ACC/AHA guidelines for the management of patients with AMI.J Am Coll Cardiol 1996;28:13281428Thrombolysis or PCI in AMI Contraindications for fibrinolytics in AMIPrevious large-scale randomized thrombolytic studies would suggest that only 15-20%of Acute MI(AMI)patients are considered eligible for reperfusion therapy by conventional criteriaMore recent observational studies*with broader inclusion criteria would estimate that approximately 45 to 50%of AMI pts were eligible(ie.12 hrs symptom onset,chest pain with 2mm ST in any 2 contiguous ECG leads or new LBBB)and 32-45%of pts actually received thrombolytic agents.Thrombolysis or PCI in AMI Eligibility for Thrombolysis in AMI PatientsKarlson BW et al Circ 1990;82:1140-6,*French JK et al BMJ 1996;312:1637-41*Reikvm et al Int J Cardiol 1997;61:79-83Not every patient is eligible for thrombolytic treatmentCerebral/vascular bleed and re-infarctionPercent AMI pts with TIMI 3 flow following thrombolysis is less than ideal Thrombolysis or PCI in AMI Limitations of Thrombolysis in AMI PatientsReteplaseN=8260Reteplase+Reopro N=8326OR(95%CI)P value30-day mortality5.9%5.6%0.95(0.84-1.08)0.43Re-MI up to 7 days3.52.30.66(0.72-0.93)75yrs1.12.11.91(0.95-3.84)0.069Sever/Mod.Bleed2.34.62.03(1.7-2.42)0.0001Thrombolysis or PCI in AMI GUSTO V:Primary and Secondary Endpoints16,588 pts within 6hrs of STEMI randomized to standard dose of reteplase(n=8260)or-dose reteplase and full-dose Reopro(n=8328).The GUSTOV Investigators.Lancet 2001;357:1905-14Not every patient is eligible for thrombolytic treatmentCerebral/vascular bleedPercent AMI pts with TIMI 3 flow following thrombolysis is less than ideal Thrombolysis or PCI in AMI Limitations of Thrombolysis in AMI PatientsThe 90 Minute Wall:The 90 Minute Wall:60%Rates of TIMI Grade 3 Flow%TIMI 3 Flow%TIMI 3 FlowIncidence and Patho-anatomy of AMIFibrinolysis for AMIFibrinolysis Vs.Primary PCIAdjunct Pharmacology and StrategiesCurrent Recommendations in Treatment of AMIThrombolysis or PCI in AMI Grines,C.L.et al.N Engl J Med 1993;328:673-679Thrombolysis or PCI in AMI PAMI:In-Hospital Reinfarction and Death395 Pts were enrolled in 12 sites with AMI within 12 hrs of symptom onset and randomized to immediate PTCA(n=195)vs.tPA(n=200)By 6 months,reMI or death had occurred in 15.8%of pts treated with tPA and 8.5%treated with PTCA(p=0.02).Thrombolysis or PCI in AMI Short(4-6wks)-term clinical Outcomes Post 1 PTCA Vs.ThrombolysisKeeley et al,Lancet 2003;361:13-20Summary of 23 trials totaling 7,739 pts(PTCA=3,872 and Thrombolysis=3,867 pts)27%65%54%47%Thrombolysis or PCI in AMI Advantages and Disadvantages of 1 PTCA Vs.ThrombolysisAdvantagesDisadvantagesSuperior vessel patency and TIMI 3 flowLack of generalized availabilityEarly definition of coronary anatomy allows risk stratificationDelay in mobilizing cath labReduced rates of recurrent ischemia,re-MI,death,and strokeSkilled interventional cardiologys requiredImproved survival in high risk patientsNo large single mortality trial data availableReduced intracranial bleedShorter length of hospital stayAllows reperfusion when thrombolytics are contra-indicatedIncidence and Patho-anatomy of AMIFibrinolysis for AMIFibrinolysis Vs.Primary PCIAdjunct Pharmacology and StrategiesCurrent Recommendations in Treatment of AMIThrombolysis or PCI in AMI Thrombolysis or PCI in AMI The ADMIRAL TrialMulti-center 300 pts randomized,double-blind placebo controlled study to demonstrate the superiority of abciximab over placebo in primary PTCA with stenting in acute myocardial infarctionMontalescot G et al NEJM 2001;344:1895-1903Thrombolysis or PCI in AMI ADMIRAL:Frequency of TIMI III FLOWP=0.01P=0.04P=0.33P=0.04Montalescot G et al NEJM 2001;344:1895-1903Thrombolysis or PCI in AMI ADMIRAL:Composite Endpoint 6 monthP=0.13Montalescot G et al NEJM 2001;344:1895-1903P=0.32P=0.049P=0.02Reopro improves coronary patency before stenting,and clinical outcome at 30 days and 6 monthsN=149N=151Thrombolysis or PCI in AMI CAPTIM:Study DesignPrimary Composite Endpoint-30-day Death,Reinfarction,Disabling StrokeBonnefoy E,et al.Lancet 2002;360:825-9AMI within 6 hours1200 planned840 enrolledPrehospitalThrombolysisn=419PrimaryAngioplastyn=421Comparison of Angioplasty and Prehospital Thrombolysis in Acute Myocardial InfarctionThrombolysis or PCI in AMI CAPTIM:Study DesignP=0.61P=0.13P=0.12P=0.29Bonnefoy E,et al.Lancet 2002;360:825-9Primary PTCA was not better than pre-hospital thrombolysis with transfer for possible rescue PTCA in pts with 4 mm elevation),Sx 12 hrs5 PCI centers(n=443)and 22 referring hospitals(n=1,129),transfer in 3 hrsLytic therapyFront-loaded tPA 100 mg(n=782)Death/Re-MI/Stroke at 30 DaysThrombolysis or PCI in AMI DANAMI-2:Study DesignPrimary PCIwith transfer(n=567)Primary PCIwithout transfer(n=223)Stopped early by safety and efficacy committeeAnderson HR et al NEJM 2003;349:733-42Death/MI/Stroke(%)LyticPrimary PCIP=0.0003P=0.002CombinedTransfer SitesP=0.048Non-Transfer SitesThrombolysis or PCI in AMI DANAMI-2:Primary ResultsRRR 45%LyticPrimary PCILyticPrimary PCIRRR 40%RRR 45%Anderson HR et al NEJM 2003;349:733-42LyticPrimary PCIP=0.35DeathThrombolysis or PCI in AMI DANAMI-2:ResultsLyticPrimary PCIP=0.15StrokeLyticPrimary PCIP0.0001Recurrent MIAnderson HR et al NEJM 2003;349:733-4296%OF PTS WERE TRANSFERRED FROM REFERRAL HOSP.TO INVASIVE CETNER WITHIN 2 HRSThrombolysis or PCI in AMI Prague 2:Long distant transfer vs.Thrombolysis in AMIMulticenter Czech study involving 850 pts with ST elevation MI within 12 hrs of symptom onset.Primary end point was 30-day moratlity,and composite secondary end points were:death,re-MI,stroke at 30 days.Widimsky P et al Eur Heart J 2003;24:94-104Thrombolysis or PCI in AMI Prague 2:Long distant transfer vs.Thrombolysis in AMIP=0.12P=NSP0.02P 3 hrs of symptom onset,PCI results in better clinical outcome despite long distance transfer.Widimsky P et al Eur Heart J 2003;24:94-104Time to PerfusionVolume of Hospital and experience of OperatorThrombolysis or PCI in AMIWhat Else is Important in AMI Treatment Strategy?Additional important parameters to maximize quality of care in the treatment of AMI patientsN=27,080,P 0.00001Thrombolysis or PCI in AMINRMI-2:Primary PCI Door-to-Balloon time vs.MortalityDoor-to-Balloon Time(minutes)Thrombolysis or PCI in AMI Mortality rates with primary PCI as a function of PCI-related time delayP=0.006020406080100PCI-Related Time Delay(door-to-balloon-door to needle)Absolute Risk Difference in Death(%)Absolute Risk Difference in Death(%)-5051015Circle sizes=sample size of the individual studySolid line=weighted meta-regression Nallamothu BK,Bates ER.Am J Cardiol.2003;92:824-662 minBenefitFavors PCIHarmFavors LysisFor Every 10 min delay to PCI:1%reduction in mortality difference towards lyticsMeta-analysis of 23 studies with 7419 ptsTime to PerfusionVolume of Hospital and experience of OperatorThrombolysis or PCI in AMIWhat Else is Important in AMI Treatment Strategy?Additional important parameters to maximize quality of care in the treatment of AMI patientsThrombolysis or PCI in AMINRMI-2:Hospital Volume of Primary PCI vs.Mortality N=4,740 14,078 8,262P=0.033P=0.00010.860.67Incidence and Patho-anatomy of AMIFibrinolysis for AMIFibrinolysis Vs.Primary PCIAdjunct Pharmacology and StrategiesCurrent Recommendations in Treatment of AMIThrombolysis or PCI in AMI Thrombolysis or PCI in AMI Importance of Early Reperfusion Therapy in STEMIOutcomes Dependent Upon:Time to treatment-TIME IS STILL MUSCLE Early and full restoration in coronary blood flowSustained restoration of flow Thrombolysis or PCI in AMI Pharmacological ReperfusionAvailable ResourcesClass I1.STEMI patients presenting to a facility without the capability for expert,prompt intervention with primary PCI within 90 minutes of first medical contact should undergo fibrinolysis unless contraindicated.(Level of Evidence:A)Antman et al.JACC 2004;44:682.Thrombolysis or PCI in AMI Fibrinolytic TherapyClass I In the absence of contraindication,fibrinolytic therapyshould be administered to STEMI patients with symptom onset within the prior 12 hours&ST elevation 2.In the absence of contraindications,fibrinolytic therapyshould be administered to STEMI patients with symptom onset within the prior 12 hours and new or presumably new LBBB.(Level of Evidence:A)Antman et al.JACC 2004;44:682-3.Thrombolysis or PCI in AMI Primary Percutaneous Coronary InterventionClass I 1.General considerations:The procedure should be supported by experienced personnel in an appropriate laboratory environment(performs more than 200 PCI procedures per year,of which at least 36 are primary PCI for STEMI,and has cardiac surgery capability).(Level of Evidence:A)Antman et al.JACC 2004;44:682.Thrombolysis or PCI in AMI Primary Percutaneous Coronary InterventionClass I 2.Specific Considerations:a.Primary PCI should be performed as quickly as possible,with a goal of a medical contactto-balloon or door-to-balloon time of within 90 minutes.(Level of Evidence:B)b.If the symptom duration is within 3 hours and the expected door-to-balloon time minus the expected door-to-needle time is:i)within 1 hour,primary PCI is generally preferred.(Level of Evidence:B)ii)greater than 1 hour,fibrinolytic therapy(fibrin-specific agents)is generally preferred.(Level of Evidence:B)c.If symptom duration is greater than 3 hours,primary PCI is generally preferred and should be performed with a medical contactto-balloon or door-to-balloon time as brief as possible,with a goal of within 90 minutes.(Level of Evidence:B)Antman et al.JACC 2004;44:684Primary Percutaneous Coronary Intervention Facilitated PCIClass IIb1.Facilitated PCI might be performed as a reperfusion strategy in higher-risk patients when PCI is not immediately available and bleeding risk is low.(Level of Evidence:B)Antman et al.JACC 2004;44:686.Fibrinolytic Therapy Combination Therapy with GP IIb/IIIaClass III1.Combination pharmacological reperfusion with abciximab and half-dose reteplase or tenecteplase should not be given to patients aged greater than 75 years because of an increased risk of ICH.(Level of Evidence:B)Antman et al.JACC 2004;44:683.Adapted from Figure 3;Antman et al.JACC 2004;44:682If presentation is 75 PPCI cases per year/Team experience 36 PPCI cases per year Delay to invasive strategyProlonged transport(Door-to Balloon)(Door-to-needle)time is 1 HRMedical contact-to-balloon time is than 90 minThrombolysis or PCI in AMIWhich Strategy to Choose?Adapted from Figure 3;Antman et al.JACC 2004;44:682An invasive strategy is generally preferred if:Skilled PCI laboratory available with surgical backup Medical contact-to-balloon time is than 90 min(Door-to Balloon)(Door-to-needle time)is 1 hr High risk from STEMICardiogenic shockKillip class greater than or equal to 3 Contraindications to fibrinolysis,including increasedrisk of bleeding and ICH Late presentationSymptom onset was more than 3 hours ago Diagnosis of STEMI is in doubtThrombolysis or PCI in AMIWhich Strategy to Choose?

    注意事项

    本文(溶栓和急诊PCI在急性心梗治疗中的作用课件.ppt)为本站会员(飞****2)主动上传,淘文阁 - 分享文档赚钱的网站仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知淘文阁 - 分享文档赚钱的网站(点击联系客服),我们立即给予删除!

    温馨提示:如果因为网速或其他原因下载失败请重新下载,重复下载不扣分。




    关于淘文阁 - 版权申诉 - 用户使用规则 - 积分规则 - 联系我们

    本站为文档C TO C交易模式,本站只提供存储空间、用户上传的文档直接被用户下载,本站只是中间服务平台,本站所有文档下载所得的收益归上传人(含作者)所有。本站仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。若文档所含内容侵犯了您的版权或隐私,请立即通知淘文阁网,我们立即给予删除!客服QQ:136780468 微信:18945177775 电话:18904686070

    工信部备案号:黑ICP备15003705号 © 2020-2023 www.taowenge.com 淘文阁 

    收起
    展开